Skip to main content
. 2021 Dec 23;16:8309–8321. doi: 10.2147/IJN.S331909

Table 3.

Data of Cell Cycle Analysis Perturbation in HepG2 Cell Line Following Treatments with the Prepared Nanoformulations Compared to Untreated Cells

Treatment %G0-G1 %S %G2/M % Sub-G1
UT HepG 2 63.2 18.6 18.2 1.92
G+ST/PCL 69.1 14.1 16.8 16.29
G+ST/PLGA 75.6 11.9 12.5 23.88
G+ST/PCL+6 Gy 74.3 12.3 13.4 27.23
G+ST/PLGA+6 Gy 76.2 10.2 13.6 33.04